HCMT
TGTX icon

Highland Capital Management (Texas)’s TG Therapeutics TGTX Stock Holding History

Highland Capital Management (Texas)’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$7.39M Sell
854,360
-24,000
-3% -$181K 0.43% 43
2019
Q1 		$7.06M Buy
878,360
+425,000
+94% +$2.3M 0.44% 45
2018
Q4 		$1.86M Sell
453,360
-299,791
-40% -$1.49M 0.14% 119
2018
Q3 		$4.22M Buy
753,151
+283,910
+61% +$3.24M 0.23% 84
2018
Q2 		$6.17M Buy
469,241
+4,850
+1% +$66.7K 0.35% 71
2018
Q1 		$6.59M Buy
+464,391
New +$5.93M 0.34% 79

Other funds holding TGTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Highland Capital Management (Texas)'s TGTX Position: Q2 2019 in Review

Highland Capital Management (Texas) reduced its TG Therapeutics (TGTX) stake by 2.7% in Q2 2019, selling an estimated $181K and leaving 854,360 shares worth $7.39M. The position accounts for 0.43% of the portfolio, ranked #43.

Highland Capital Management (Texas) first reported a position in TGTX in Q1 2018 and has held it in 6 quarters since. 116 funds tracked by Wall St. Rank hold TGTX as of Q2 2019.

  • Highland Capital Management (Texas) held 854,360 shares of TG Therapeutics worth $7.39M as of Q2 2019.
  • Highland Capital Management (Texas) sold 24,000 TG Therapeutics shares in Q2 2019, an estimated $181K.
  • TG Therapeutics made up 0.43% of Highland Capital Management (Texas)'s portfolio in Q2 2019, its #43 holding.
  • Highland Capital Management (Texas) first reported a position in TG Therapeutics in Q1 2018 and has held it in 6 quarters since.
  • 116 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2019.

Based on Highland Capital Management (Texas)'s 13F filing for Q2 2019, filed 14 Aug 2019.